E2 ModeratePreliminaryPEM unclearCase-ControlPeer-reviewedMachine draft
Allostatic load is associated with symptoms in chronic fatigue syndrome patients.
Goertzel, Benjamin N, Pennachin, Cassio, de Souza Coelho, Lucio et al. · Pharmacogenomics · 2006 · DOI
Quick Summary
This study looked at whether ME/CFS patients have higher 'allostatic load'—a measure of stress on the body's systems including metabolism, heart function, and hormones. Researchers compared 43 ME/CFS patients to 60 healthy controls and found that ME/CFS patients with higher allostatic load reported worse physical function, more body pain, and more frequent symptoms. The study suggests the body's stress response systems may play a role in ME/CFS severity.
Why It Matters
This study provides biological plausibility for how ME/CFS symptoms may relate to cumulative physiological stress, potentially linking multiple dysfunctional body systems into a coherent framework. Understanding allostatic load as a contributor to symptom severity could inform future treatments targeting metabolic, cardiovascular, or endocrine dysfunction in ME/CFS.
Observed Findings
- Among CFS patients, high allostatic load was significantly associated with worse bodily pain compared to controls.
- Among CFS patients, high allostatic load was significantly associated with reduced physical functioning compared to controls.
- Among CFS patients, high allostatic load was significantly associated with greater symptom frequency and intensity compared to controls.
- Allostatic load index as a composite predicted these health measures better than any individual component among CFS patients but not healthy controls.
Inferred Conclusions
- Allostatic load—a composite measure of metabolic, cardiovascular, and HPA-axis dysfunction—is associated with symptom severity in ME/CFS patients.
- The relationship between allostatic load and symptoms appears disease-specific, not generalizable to healthy populations.
- Multisystem physiological stress may be a relevant factor in ME/CFS symptom expression.
Remaining Questions
- Does allostatic load change over time in ME/CFS patients, and does this correlate with symptom fluctuation?
- Which specific components of the allostatic load index (metabolic, cardiovascular, or HPA-axis) drive symptom severity, and do they differ across patient subgroups?
What This Study Does Not Prove
This study does not establish causation—elevated allostatic load may result from rather than cause ME/CFS symptoms. The cross-sectional design cannot determine whether reducing allostatic load would improve symptoms. The study also does not validate allostatic load as a diagnostic marker or explain the biological mechanisms linking specific system dysfunctions to particular symptoms.
Tags
Symptom:Cognitive DysfunctionPainFatigue
Biomarker:MetabolomicsBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.2217/14622416.7.3.485
- PMID
- 16610958
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →